glp 1 zepbound GLP1 Drug Use For Weight Loss Has Soared Costing Billions Lilly lowers self-pay prices of
Description
Since tirzepatide is already approved and well known, doctors have a solid basis for talking about how it can be used to treat obesity
Members need solutions that adapt to their lives not the other way around
This result may be related to insufficient sample size (Rizza et al., 2023)
The real problem seems to be retention
